Recent findings have revealed that NETs activate ATP-citrate lyase (ACLY) in RA-FLS, driving lipogenesis, cell proliferation, migration, invasiveness, and NF-κB-mediated inflammation, ultimately exacerbating synovial inflammation and joint damage in RA (39). Here, ACLY is linked to rheumatoid arthritis.